Recalls & Warnings August 01, 2013 Maker of Algae Products Warned For Drug Claims, Manufacturing Violations On March 8, 2013, the FDA issued a warning letter to Algaen Corporation following a facility inspection and website review which found statements made about the company's AlgaBerry products to be drug claims
The innovation pipeline is now dominated by a critical debate surrounding dual agonists versus single agonists, with multi-receptor compounds demonstrating superior clinical outcomes
Thyroid autoimmunity, hypothyroidism and ovarian reserve: a cross-sectional study of 5000 women based on age-specific AMH values
Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR